SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-3 - Registration statement by foreign private issuers:
SEC Accession No. 0001193125-19-280455
Filing Date
2019-10-31
Accepted
2019-10-31 16:09:03
Documents
9

Document Format Files

Seq Description Document Type Size
1 FORM F-3 d818392df3.htm F-3 721990
2 EX-5.1 d818392dex51.htm EX-5.1 20454
3 EX-23.1 d818392dex231.htm EX-23.1 1826
4 GRAPHIC g818392d0001_818392.jpg GRAPHIC 49429
5 GRAPHIC g818392d0002_818392.jpg GRAPHIC 48329
6 GRAPHIC g818392d0003_818392.jpg GRAPHIC 49383
7 GRAPHIC g818392dsp90.jpg GRAPHIC 3327
8 GRAPHIC g818392g02q20.jpg GRAPHIC 33289
9 GRAPHIC g818392g05b00.jpg GRAPHIC 131603
  Complete submission text file 0001193125-19-280455.txt   1180628
Mailing Address 83 CLEMENCEAU AVENUE #12-03 UE SQUARE SINGAPORE U0 239920
Business Address 83 CLEMENCEAU AVENUE #12-03 UE SQUARE SINGAPORE U0 239920 65 6222 4235
ASLAN Pharmaceuticals Ltd (Filer) CIK: 0001722926 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: F-3 | Act: 33 | File No.: 333-234405 | Film No.: 191183747
SIC: 2834 Pharmaceutical Preparations